(Adnkronos) - “Il settore farmaceutico è uno dei primi settori nel campo della ricerca e dello sviluppo. Si pensi che, nel 2023, se la manifattura ha investito 100 il settore farmaceutico ha investito otto volte in più. Sono dati interessanti tanto per l’Italia quanto per l’Europa”. Ad affermarlo a Bari è stata Daniela Bianco Responsabile LifeCare The European House Ambrosetti, a margine della presentazione di uno studio che vede protagoniste AstraZeneca e Alexion.
Category
🗞
NewsTranscript
00:00The pharmaceutical sector is one of the most attractive sectors of our economy,
00:07because it is one of the leading sectors for investment, research and development.
00:10We think that in 2023, if manufacturers have invested 100%,
00:14the pharmaceutical sector has invested 8 times more.
00:16So it is certainly an interesting intensity for the country and not only, but also for Europe.
00:22However, it is a sector that today is going through a phase of strong dynamism at the global level,
00:26but of loss of competitiveness and productivity at the European level, as the Draghi relationship also says.
00:32So what should we do?
00:34We must certainly invest to increase the attractiveness of our country system,
00:39with targeted investments, with a vision of a life science strategy,
00:44which is what our country does not have today,
00:47even if a table has been set at the MIMIT for the definition of industrial policy,
00:51however, it is necessary to develop a real plan of the life science strategy,
00:56as other countries are already doing, such as the United Kingdom, France, Germany and also Spain,
01:02because it is essential for us not to lose competitiveness compared to these countries
01:07and therefore to increase this quota of investments in the pharmaceutical sector,
01:11which today we have in research and development only 1%, to make it grow in the coming years.
01:21Transcription by ESO, translation by —